Pioglitazone was associated with lower risk for adverse cardiovascular events than rosiglitazone in older patients: Commentary

Ananda Basu

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)JC2-13
JournalAnnals of internal medicine
Volume152
Issue number4
DOIs
StatePublished - Feb 16 2010

ASJC Scopus subject areas

  • Internal Medicine

Cite this